These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inhibition of tat-mediated HIV-1-LTR transactivation and virus replication by sulfhydryl compounds with chelating properties. Demirhan I; Chandra A; Sarin PS; Hasselmayer O; Hofmann D; Chandra P Anticancer Res; 2000; 20(4):2513-7. PubMed ID: 10953320 [TBL] [Abstract][Full Text] [Related]
7. Anti-Tat and anti-HIV activities of trimers of n-alkylglycines. Márquez N; Sancho R; Macho A; Moure A; Masip I; Messeguer A; Muñoz E Biochem Pharmacol; 2006 Feb; 71(5):596-604. PubMed ID: 16405868 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional control of HIV replication by multiple modulators and their implication for a novel antiviral therapy. Victoriano AF; Okamoto T AIDS Res Hum Retroviruses; 2012 Feb; 28(2):125-38. PubMed ID: 22077140 [TBL] [Abstract][Full Text] [Related]
9. Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways. Olmedo DA; López-Pérez JL; Del Olmo E; Bedoya LM; Sancho R; Alcamí J; Muñoz E; Feliciano AS; Gupta MP Molecules; 2017 Feb; 22(2):. PubMed ID: 28218730 [TBL] [Abstract][Full Text] [Related]
10. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies. Quivy V; De Walque S; Van Lint C Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137 [TBL] [Abstract][Full Text] [Related]
11. A 1,8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replication. Massari S; Daelemans D; Barreca ML; Knezevich A; Sabatini S; Cecchetti V; Marcello A; Pannecouque C; Tabarrini O J Med Chem; 2010 Jan; 53(2):641-8. PubMed ID: 19958026 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of human immunodeficiency virus type 1 transcription by N-aminoimidazole derivatives. Stevens M; Balzarini J; Lagoja IM; Noppen B; François K; Van Aerschot A; Herdewijn P; De Clercq E; Pannecouque C Virology; 2007 Aug; 365(1):220-37. PubMed ID: 17459445 [TBL] [Abstract][Full Text] [Related]
13. NF-kappaB-dependent control of HIV-1 transcription by the second coding exon of Tat in T cells. Mahlknecht U; Dichamp I; Varin A; Van Lint C; Herbein G J Leukoc Biol; 2008 Mar; 83(3):718-27. PubMed ID: 18070983 [TBL] [Abstract][Full Text] [Related]
14. Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells. Wang M; Xu Z; Tu P; Yu X; Xiao S; Yang M Bioorg Med Chem Lett; 2004 May; 14(10):2585-8. PubMed ID: 15109657 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors. Chen S; Chen R; He M; Pang R; Tan Z; Yang M Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787 [TBL] [Abstract][Full Text] [Related]
16. An allosteric drug, o,o'-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B. Shoji S; Furuishi K; Ogata A; Yamataka K; Tachibana K; Mukai R; Uda A; Harano K; Matsushita S; Misumi S Biochem Biophys Res Commun; 1998 Aug; 249(3):745-53. PubMed ID: 9731208 [TBL] [Abstract][Full Text] [Related]
17. Influence of generation 2-5 of PAMAM dendrimer on the inhibition of Tat peptide/ TAR RNA binding in HIV-1 transcription. Wang W; Guo Z; Chen Y; Liu T; Jiang L Chem Biol Drug Des; 2006 Dec; 68(6):314-8. PubMed ID: 17177893 [TBL] [Abstract][Full Text] [Related]
18. Selective small molecules blocking HIV-1 Tat and coactivator PCAF association. Zeng L; Li J; Muller M; Yan S; Mujtaba S; Pan C; Wang Z; Zhou MM J Am Chem Soc; 2005 Mar; 127(8):2376-7. PubMed ID: 15724976 [TBL] [Abstract][Full Text] [Related]
19. Anti-HIV activity of some synthetic lignanolides and intermediates. Sancho R; Medarde M; Sánchez-Palomino S; Madrigal BM; Alcamí J; Muñoz E; San Feliciano A Bioorg Med Chem Lett; 2004 Sep; 14(17):4483-6. PubMed ID: 15357976 [TBL] [Abstract][Full Text] [Related]
20. Targeting of HIV-1 Tat traffic and function by transduction-competent single chain antibodies. Theisen DM; Pongratz C; Wiegmann K; Rivero F; Krut O; Krönke M Vaccine; 2006 Apr; 24(16):3127-36. PubMed ID: 16497417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]